Trescal Acquires Facility Monitoring Systems to Bolster UK Contamination Control Services Market

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

Facility Monitoring Systems (FMS), a contamination control solutions provider based in Malvern, United Kingdom, announced on Feb. 3, 2025 that it has joined the Market Harborough, UK, calibration services company Trescal. In a company press release, the transaction is referred to as a “strategic acquisition” by Trescal of FMS (1).

“Becoming part of the Trescal family is a transformative opportunity for FMS,” Deborah Haisman, FMS commercial director, said in the press release (1). “We are proud of our strong reputation and the trust our customers place in us. Working with Trescal’s experts and calibration solutions will allow us to enhance our services, expand our reach, and deliver even greater value to our customers in all contamination control sectors in the UK and Ireland.”

Among the benefits FMS said the new partnership would provide to customers in the UK and Ireland are expanded resources and service capabilities, cutting-edge cleanroom contamination control solutions, and a stronger commitment to customer support (1). While FMS has specialized in the design, installation, and maintenance of environmental monitoring systems, Trescal’s focus has been on calibration and metrology services.

“By bringing FMS into the Trescal family, we are boosting our capabilities and strengthening our commitment to serving highly regulated industries,” Karolina Lachi-Kolarova, managing director of Trescal in the UK, Ireland, and Norway, said in the release. “The complementary skills and experience of the two companies is a powerful asset to our global business.”

Astech Ltd is the strategic partner to FMS in Ireland and will continue to be a direct interface for customers in the Irish market, according to the release (1). TSI Inc., of Shoreview, Minn., in the United States, has endorsed the transaction; TSI is a longtime principal to FMS, the Gold Channel Partner for TSI’s contamination products in the UK and Ireland.

“We are confident that its integration with Trescal will unlock new opportunities for innovation and growth,” Simon Tebb, Europe, Middle East and Africa sales manager for Controlled Environments at TSI, said in the release. “TSI looks forward to continuing our collaboration with FMS as part of Trescal to advance contamination control technologies in the UK and Ireland.”

This transaction is just one of several mergers and acquisitions that have been announced so far in 2025. On January 7, Molex, the parent company of Phillips Medisize, said it had completed an acquisition of Vectura Group (2). On January 13, Telix Pharmaceuticals entered into an asset purchase agreement with ImaginAb for a pipeline of next-generation therapeutic candidates, a proprietary and novel biologics technology platform, and a protein engineering and discovery research facility (3). And on January 28, Lantheus Holdings said it was acquiring the clinical stage radiopharmaceutical contract development and manufacturing organization Evergreen Theragnostics (4).

References

1. Facility Monitoring Systems. FMS Acquired by Trescal, Driving Growth and Innovation in the Contamination Control Industry. Press Release. Feb. 3, 2025.
2. Phillips Medisize. Phillips Medisize Expands Its Inhalation Drug Delivery Capabilities. Press Release. Jan. 7, 2025.
3. Telix Pharmaceuticals. Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform. Press Release. Jan. 13, 2025.
4. Lantheus. Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader. Press Release. Jan. 28, 2025.